Education
About Us
Working with TipRanks
Follow Us
Arrowhead Pharmaceuticals (GB:0HI3)
LSE:0HI3
RESEARCH TOOLSreports
Arrowhead Pharmaceuticals (0HI3) Ownership Overview
4.52% Insiders
19.00% Mutual Funds
24.39% Other Institutional Investors
28.24% ETFs
23.84% Public Companies and Individual Investors
The ownership structure of Arrowhead Pharmaceuticals (GB:0HI3) stock is a mix of institutional, retail, and individual investors. Approximately 71.64% of the company’s stock is owned by Institutional Investors, 4.52% is owned by Insiders, and 23.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 07, 2025 | xxxxxxxxxxxxx | $196900 | |
| Apr 03, 2024 | James C Hamilton Chief Discovery/trans Medicine | xxxxxxxxxxxxx | $168180 |
| Mar 20, 2024 | Hongbo Lu Director | xxxxxxxxxxxxx | $82990 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $232650 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $2687253 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $11821440 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $15795271 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,418,357 | Institution | 14.61% | 365,309,693 | |
| 11,759,787 | Institution | 9.33% | 233,243,615 | |
| 10,177,542 | Institution | 8.07% | 201,861,368 | |
| 5,232,000 | Institution | 4.15% | 103,771,488 | |
| 3,773,802 | Insider | 2.99% | 74,849,589 | |
| 3,606,440 | Institution | 2.86% | 71,530,131 | |
| 1,561,941 | Institution | 1.24% | 30,979,538 | |
| 1,301,965 | Institution | 1.03% | 25,823,174 | |
| 1,249,556 | Institution | 0.99% | 24,783,694 | |
| 1,222,835 | Institution | 0.97% | 24,253,709 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,177,542 | Institution | 8.07% | 201,861,368 | |
| 1,561,941 | Institution | 1.24% | 30,979,538 | |
| 1,301,965 | Institution | 1.03% | 25,823,174 | |
| 1,249,556 | Institution | 0.99% | 24,783,694 | |
| 1,222,835 | Institution | 0.97% | 24,253,709 | |
| 1,109,494 | Institution | 0.88% | 22,005,704 | |
| 807,099 | Institution | 0.64% | 16,008,002 | |
| 682,597 | Institution | 0.54% | 13,538,629 | |
| 661,739 | Institution | 0.52% | 13,124,931 | |
| 548,851 | Institution | 0.44% | 10,885,911 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Arrowhead Pharmaceuticals (GB:0HI3)?
According to the latest TipRanks data, approximately 24.39% of the company's stock is held by institutional investors, 4.52% is held by insiders, and 23.84% is held by retail investors.
What percentage of Arrowhead Pharmaceuticals (GB:0HI3) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.39% of Arrowhead Pharmaceuticals (GB:0HI3) stock is held by institutional investors.
What percentage of Arrowhead Pharmaceuticals (GB:0HI3) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.84% of Arrowhead Pharmaceuticals (GB:0HI3) stock is held by retail investors.
Who owns the most shares of Arrowhead Pharmaceuticals (GB:0HI3)?
iShares owns the most shares of Arrowhead Pharmaceuticals (GB:0HI3).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.